Literature DB >> 31061659

Microbiome-Based Treatment Strategies for Irritable Bowel Syndrome.

William D Chey1.   

Abstract

Entities:  

Year:  2019        PMID： 31061659      PMCID： PMC6495414     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  4 in total

1.  Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial.

Authors:  Peter Holger Johnsen; Frank Hilpüsch; Jorunn Pauline Cavanagh; Ingrid Sande Leikanger; Caroline Kolstad; Per Christian Valle; Rasmus Goll
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-11-01

2.  A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome.

Authors:  Joanna Dionne; Alexander C Ford; Yuhong Yuan; William D Chey; Brian E Lacy; Yuri A Saito; Eamonn M M Quigley; Paul Moayyedi
Journal:  Am J Gastroenterol       Date:  2018-07-26       Impact factor: 10.864

3.  Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome.

Authors:  Alexander C Ford; Lucinda A Harris; Brian E Lacy; Eamonn M M Quigley; Paul Moayyedi
Journal:  Aliment Pharmacol Ther       Date:  2018-10-08       Impact factor: 8.171

4.  Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials.

Authors:  P Schoenfeld; M Pimentel; L Chang; A Lembo; W D Chey; J Yu; C Paterson; E Bortey; W P Forbes
Journal:  Aliment Pharmacol Ther       Date:  2014-04-03       Impact factor: 8.171
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.